1-215675168-T-C

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000307340.8(USH2A):ā€‹c.12743A>Gā€‹(p.His4248Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00108 in 1,614,104 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H4248L) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.0058 ( 6 hom., cov: 32)
Exomes š‘“: 0.00058 ( 6 hom. )

Consequence

USH2A
ENST00000307340.8 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 1.90
Variant links:
Genes affected
USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

PM1
In a domain Fibronectin type-III 27 (size 104) in uniprot entity USH2A_HUMAN there are 33 pathogenic changes around while only 13 benign (72%) in ENST00000307340.8
BP4
Computational evidence support a benign effect (MetaRNN=0.008660406).
BP6
Variant 1-215675168-T-C is Benign according to our data. Variant chr1-215675168-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 48407.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-215675168-T-C is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00579 (882/152296) while in subpopulation AFR AF= 0.02 (832/41558). AF 95% confidence interval is 0.0189. There are 6 homozygotes in gnomad4. There are 432 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
USH2ANM_206933.4 linkuse as main transcriptc.12743A>G p.His4248Arg missense_variant 63/72 ENST00000307340.8 NP_996816.3 O75445-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
USH2AENST00000307340.8 linkuse as main transcriptc.12743A>G p.His4248Arg missense_variant 63/721 NM_206933.4 ENSP00000305941.3 O75445-1
USH2AENST00000674083.1 linkuse as main transcriptc.12743A>G p.His4248Arg missense_variant 63/73 ENSP00000501296.1 O75445-3

Frequencies

GnomAD3 genomes
AF:
0.00580
AC:
882
AN:
152178
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0201
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00229
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00478
GnomAD3 exomes
AF:
0.00148
AC:
372
AN:
250834
Hom.:
2
AF XY:
0.00100
AC XY:
136
AN XY:
135540
show subpopulations
Gnomad AFR exome
AF:
0.0208
Gnomad AMR exome
AF:
0.000724
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000530
Gnomad OTH exome
AF:
0.000327
GnomAD4 exome
AF:
0.000585
AC:
855
AN:
1461808
Hom.:
6
Cov.:
37
AF XY:
0.000484
AC XY:
352
AN XY:
727194
show subpopulations
Gnomad4 AFR exome
AF:
0.0206
Gnomad4 AMR exome
AF:
0.000827
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000464
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000342
Gnomad4 OTH exome
AF:
0.00134
GnomAD4 genome
AF:
0.00579
AC:
882
AN:
152296
Hom.:
6
Cov.:
32
AF XY:
0.00580
AC XY:
432
AN XY:
74476
show subpopulations
Gnomad4 AFR
AF:
0.0200
Gnomad4 AMR
AF:
0.00229
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.00473
Alfa
AF:
0.000691
Hom.:
1
Bravo
AF:
0.00634
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.0175
AC:
77
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00176
AC:
214
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesDec 12, 2017- -
Benign, criteria provided, single submitterclinical testingGeneDxSep 19, 2019- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsFeb 15, 2019- -
not specified Benign:3
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMay 15, 2012His4248Arg in Exon 63 of USH2A: This variant is not expected to have clinical si gnificance because it has been identified in 1.7% (65/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs145830318). -
Usher syndrome type 2A Benign:2
Benign, no assertion criteria providedclinical testingNatera, Inc.Dec 10, 2019- -
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabNov 04, 2023- -
Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsSep 27, 2021- -
Retinitis pigmentosa 39 Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabNov 04, 2023- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.24
CADD
Benign
15
DANN
Benign
0.87
DEOGEN2
Benign
0.19
T
Eigen
Benign
-0.42
Eigen_PC
Benign
-0.35
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.56
T
MetaRNN
Benign
0.0087
T
MetaSVM
Benign
-0.70
T
MutationAssessor
Benign
1.6
L
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.35
T
PROVEAN
Uncertain
-3.1
D
REVEL
Benign
0.13
Sift
Benign
0.14
T
Sift4G
Benign
0.080
T
Polyphen
0.015
B
Vest4
0.13
MVP
0.87
MPC
0.044
ClinPred
0.0053
T
GERP RS
4.1
Varity_R
0.29
gMVP
0.49

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs145830318; hg19: chr1-215848510; API